Hikma Pharmaceuticals PLC 2020 SR
The report highlights Hikma's commitment to sustainability and corporate social responsibility during 2020. Key achievements include doubling medicine donations to $4.1 million, maintaining membership in the FTSE4Good Index, and supporting over 8,600 employees during the pandemic. The company made progress in aligning with TCFD recommendations and reported a 4% decrease in Scope 1 and 2 emissions since 2017. Additionally, Hikma focused on diversity through a new task force and continued its long-standing support for the UN Global Compact and Sustainable Development Goals.
Company: Hikma Pharmaceuticals PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2020
Type: SR
Pages: 33
Back to company
Hikma Pharmaceuticals PLC
Sustainability Report
The report highlights Hikma's commitment to sustainability and corporate social responsibility during 2020. Key achievements include doubling medicine donations to $4.1 million, maintaining membership in the FTSE4Good Index, and supporting over 8,600 employees during the pandemic. The company made progress in aligning with TCFD recommendations and reported a 4% decrease in Scope 1 and 2 emissions since 2017. Additionally, Hikma focused on diversity through a new task force and continued its long-standing support for the UN Global Compact and Sustainable Development Goals.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Employees